Federated Pharmacovigilance: GLP-1RA vs. DPP4i
Multi-site causal inference comparing cardiovascular outcomes of GLP-1 receptor agonists and DPP-4 inhibitors. Uses negative control outcomes for bias correction and factor model approaches for unmeasured confounding.